Pine Labs Limited
Pine Labs Limited (PINELABS): company summary
The company's business improved significantly, with annual revenue rising 19.2% and annual net profit swinging from a loss to a profit.
Pine Labs Limited (PINELABS) is a small-cap Financial Services company valued at ₹19,065 crore operating in Financial Technology (Fintech) on the NSE and BSE.
- Recent price move
- Pine Labs Limited last traded at ₹166.54, modestly down 0.94% on the day.
- Recent developments
- On 2026-09-21, Mastercard announced a plan to exit Pine Labs through a block deal valued at up to ₹893 crore, selling up to 49.7 million shares. On the same day, it was reported that Mastercard Asia Pacific may divest 4.3% equity worth ₹892.5 crore in a block deal. On 2026-09-22, Pine Labs shares worth ₹934 crore changed hands in a block deal, with Mastercard Asia likely as the seller. Additionally, on 2026-09-22, the company's shift to transaction-led revenue received a boost from UPI MDR, with affordability revenue expected to grow around 27% CAGR over FY26-28.
- Financial performance
- The company's business improved significantly, with annual revenue rising 19.2% and annual net profit swinging from a loss to a profit. The latest quarter saw revenue rise 19.6% and net profit jump 291.4% compared to the same quarter a year earlier.
- Valuation multiples
- The stock trades at 158.6 times earnings, a premium to the Financial Services median of 19.3, 3.39 times book value.
- Things to watch
- The stock is 41.0% below its 52-week high. Foreign institutional holding increased by 4.69 percentage points, but domestic institutional holding rose by 13.01 percentage points. The company's return on equity is 1.9%, and return on capital employed is 3.5%, indicating low profitability relative to capital used.
- Where it stands
- Pine Labs reported a significant improvement in its financials, with net profit rising sharply in the latest quarter. The company's market cap is ₹19,244 crore, and its stock is 41.0% below its 52-week high. The most notable movement was the 291.4% increase in net profit compared to the same quarter a year earlier.
Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (10.0) and risk (6.1), but held back by valuation (0.0). Growth looks strong at 10.0, but that is offset by valuation at 0.0 and momentum at 0.9 and quality at 1.6. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Profit compounding 51% a year
- Revenue compounding 32% a year
- Loss-making in some of the last 5 years
- Quality is weak (1.6/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Financial Services stocks · Financial Technology (Fintech)
Explore Pine Labs Limited’s valuation
Free deep-dive tools · no sign-up
Pine Labs Limited peers in Financial Services
Other Financial Services stocks on the NSE & BSE. See the full Financial Services sector list.
Related tools & concepts
Value Pine Labs Limited with the ratios and calculators DocStoX uses in its analysis.

